Thursday, 23 March 2023
Trending

Business News

Crispr Therapeutics price target lowered to $55 from $63 at Citi

Organon cut to Underperform at BofA on more challenging setup


Crispr Therapeutics price target lowered to $55 from $63 at Citi

Click Here to Read the Full Original Article at TipRanks Financial Blog…